Moreover, obese patients with hepatic steatosis and steatohepatitis present with higher levels of C-reactive protein (CRP) and other inflammatory biomarkers compared with age-, sex- and obesity-matched controls4, 5. The gene discussed is CRP; the disease is fatty liver disease.